Abstract

An effective radiotherapy treatment entails maximizing radiation dose to the tumor while sparing the surrounding and normal tissues. With the advent of SBRT with extreme hypo‐fractionation in treating tumors including prostate where ablative dose is delivered in smaller number of fractions, rectum remains a dose‐limiting organ and at the risk of rectal toxicity or secondary cancer. The same limitation of rectal toxicity exists for high‐dose rate (HDR) treatments of cervical, endometrial, or prostate cancer when creating even a short distance between the anterior rectal wall and field of radiation is ideal in delivering ablative dose to the target. An effective solution to such problem is to physically displace rectum as the organ at risk. This research presents an organ retractor device that is designed to displace the rectum away from the path of radiation beam employing a Nitinol shape memory alloy that is designed for displacing the rectum upon actuation. A control system regulates the motion in a reproducible and safe manner by creating the desirable shape in moving the anterior rectal wall. The study finds the novel organ retractor device to be a promising tool that can be applied in a clinical setting for minimizing dose to the rectum during treatment of pelvic tumors, and creating the potential to deliver an ablative dose to tumor volume or to escalate the dose when needed.

Highlights

  • IntroductionDue to the radiation exposure to neighboring critical structures during prostate cancer treatment, a significant increase in cancer risk was observed for the bladder (77%) and the rectum (105%)

  • Radiation dose received by the rectal wall when using rectal balloon (John Sylvester). [Correction added on 3 January 2019, after first online publication: the article has been corrected for Figure 2 after original publication.]

  • These values were compared to the experimental data that were obtained in the Dynamic and Smart Systems Lab at University of Toledo School of engineering

Read more

Summary

Introduction

Due to the radiation exposure to neighboring critical structures during prostate cancer treatment, a significant increase in cancer risk was observed for the bladder (77%) and the rectum (105%). Over the following decade.[1] uncommon, available data show some patients develop transfusion‐dependent rectal bleeding, ulcers, or fistulas.[2] Rectal toxicity complications may require permanent colostomy and can significantly impact patients’ quality of life (QOL).[2,3] Moving the rectum away even a short distance from the plane of radiation can relax the prescription dose limitation.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call